CRVL
Corvel Corp
$63.27
+0.98 (+1.57%)
At close · Jul 13
Market Cap
$3.21B
Shares
50,691,185
Income-statement, balance-sheet and cash-flow figures extracted from the company's SEC filings — 10-K annual and 10-Q quarterly reports — and standardised for comparison across periods.
Revenue
$958.53M
+7%
FY2026
Net Income
$110.34M
+16%
FY2026
Gross Margin
24.29%
+0.9pp
FY2026
Diluted EPS
$2.14
+16.9%
FY2026
Operating Cash Flow
$155.64M
+22.2%
FY2026
Chart any reported metric, KPI or segment over time — the full statement history lives here
Search above to add metrics — fundamentals, product and segment revenue, company KPIs, valuation.
| Line Item | FY2026 | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 | FY2018 | FY2017 | FY2016 | FY2015 | FY2014 | FY2013 | FY2012 | FY2011 | FY2010 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| $958.53M | $895.59M | $795.31M | $718.56M | $646.23M | $552.64M | $592.23M | $595.74M | $558.35M | $518.69M | — | — | — | — | — | — | — | |
| $725.66M | $685.86M | $623.62M | $560.3M | $494.12M | $429.02M | $466.3M | $470.93M | $451.1M | $413.89M | $399.04M | $392.66M | $370.34M | $337.65M | $318.83M | $284.1M | $252.43M | |
| $232.86M | $209.73M | $171.69M | $158.26M | $152.11M | $123.62M | $125.92M | $124.81M | $107.25M | $104.79M | $104.54M | $99.97M | $108.48M | $91.66M | $93.84M | $96.57M | $85.54M | |
| 24.29% | 23.42% | 21.59% | 22.02% | 23.54% | 22.37% | 21.26% | 20.95% | 19.21% | 20.2% | — | — | — | — | — | — | — | |
| $89.73M | $88.9M | $76.59M | $73.71M | $67.6M | $64.45M | $65.21M | $63.3M | $59.35M | $57.24M | $58.48M | $54.41M | $51.97M | $47.77M | $50.41M | $59.17M | $42.06M | |
| $175K | $383K | $423K | $425K | $435K | $435K | $435K | $440K | $437K | $437K | $450K | $457K | $470K | $484K | $584K | — | — | |
| $31.76M | $29.54M | $26.25M | $25.12M | $23.92M | $23.44M | $22.52M | $22.98M | $21.78M | $20.95M | $19.95M | $18M | $16.41M | $15.74M | $14.72M | $12.25M | $11.99M | |
| $143.13M | $120.82M | $95.1M | $84.55M | $84.51M | $59.18M | $60.71M | $61.51M | $47.9M | $47.55M | $46.06M | $45.56M | $56.51M | $43.9M | $43.44M | $37.4M | $43.48M | |
| $32.79M | $25.66M | $18.85M | $18.19M | $18.1M | $12.82M | $13.33M | $14.81M | $12.21M | $18.07M | $17.54M | $16.97M | $22.12M | $17.17M | $16.89M | $12.74M | $17.39M | |
| $110.34M | $95.17M | $76.25M | $66.37M | $66.41M | $46.36M | $47.38M | $46.7M | $35.7M | $29.48M | $28.53M | $28.59M | $34.39M | $26.73M | $26.55M | $24.66M | $26.1M | |
| 11.51% | 10.63% | 9.59% | 9.24% | 10.28% | 8.39% | 8% | 7.84% | 6.39% | 5.68% | — | — | — | — | — | — | — | |
| USD/shares | $2.15 | $1.85 | $1.48 | $1.28 | $1.25 | $0.86 | $0.86 | $0.83 | $0.63 | $0.51 | $0.48 | $0.46 | $0.54 | $0.40 | $0.39 | $0.70 | $0.70 |
| USD/shares | $2.14 | $1.83 | $1.47 | $1.26 | $1.22 | $0.85 | $0.85 | $0.82 | $0.62 | $0.50 | $0.48 | $0.46 | $0.54 | $0.40 | $0.38 | $0.68 | $0.69 |
| shares | 51.28M | 51.38M | 51.37M | 51.98M | 53.26M | 53.79M | 54.98M | 56.38M | 56.48M | 58.25M | 59.48M | 62.01M | 63.31M | 66.77M | 68.86M | 35.4M | 37.5M |
| shares | 51.63M | 51.99M | 52.04M | 52.78M | 54.38M | 54.5M | 55.81M | 57.02M | 57.13M | 58.71M | 60.01M | 62.67M | 64.12M | 67.37M | 69.76M | 36.09M | 38.02M |
Italic rows are computed from reported lines — open a row's info icon for its formula. Values reflect the latest filing (restatements included); per-share figures on today's split basis. Click a value for its source filing.
3Y/5Y/10Y columns are trailing CAGR from the newest fiscal year; blank where an endpoint is missing or negative.
Capital Returned to Shareholders
Cash spent on share repurchases and dividends per fiscal year, as reported on the cash-flow statement. Across FY2010–FY2026: $701.95M in buybacks.
Price & Valuation
Multiples computed on the strict TTM/EV methodology — today's snapshot against the industry, and each ratio recomputed as of past filing dates.
Valuation
EV/Revenue
—
Insurance Brokers median 4.08×
EV/EBIT
—
Insurance Brokers median 17.93×
P/E (TTM)
29.57×
Insurance Brokers median 22.50×
Valuation over time computed as of each quarter's filing date
Revenue Breakdown
Annual revenue as the company disaggregates it in its own XBRL filings. Years a component wasn't reported show a dash.
Share mode is each component's slice of the reported components that year — issuers rarely tag every revenue dollar, so slices need not sum to total revenue.
By Product & Service (USD)
| Component | 2026-03-31 | 2025-03-31 | 2024-03-31 | 2023-03-31 | 2022-03-31 | 2021-03-31 | 2020-03-31 | 2019-03-31 |
|---|---|---|---|---|---|---|---|---|
| Patient Management Services | $596,703,000 | $581,192,000 | $529,995,000 | $478,751,000 | $424,050,000 | $368,853,000 | $386,814,000 | $368,198,000 |
| Network Solutions Services | $361,824,000 | $314,397,000 | $265,316,000 | $239,811,000 | $222,180,000 | $183,791,000 | $205,411,000 | $227,542,000 |
Key facts
CIK
874866
CUSIP
221006109
13F (30d)
19 filings
19 filers
Visit website
Investor relations